Two Sigma Investments, LP Pro Qr Therapeutics N.V. Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Two Sigma Investments, LP holds 68,945 shares of PRQR stock, worth $126,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,945

Previous 78,944 12.67%

Holding current value

$126,858

Previous $180,000 36.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.39 $16,498 - $23,897	-9,999 Reduced 12.67%	68,945 $114,000
Q1 2024 May 15, 2024	SELL	$1.89 - $2.85 $38,833 - $58,558	-20,547 Reduced 20.65%	78,944 $180,000
Q4 2023 Feb 14, 2024	SELL	$1.15 - $2.21 $93,440 - $179,569	-81,253 Reduced 44.95%	99,491 $196,000
Q3 2023 Nov 14, 2023	SELL	$1.3 - $1.77 $399,230 - $543,567	-307,100 Reduced 62.95%	180,744 $234,000
Q2 2023 Aug 14, 2023	BUY	$1.62 - $2.32 $113,265 - $162,207	69,917 Added 16.73%	487,844 $790,000
Q1 2023 May 15, 2023	BUY	$1.99 - $3.66 $217,831 - $400,634	109,463 Added 35.49%	417,927 $890,000
Q4 2022 Feb 14, 2023	SELL	$0.8 - $3.7 $72,826 - $336,822	-91,033 Reduced 22.79%	308,464 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$0.74 - $0.89 $4,624 - $5,561	6,249 Added 1.59%	399,497 $297,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.0 $196,632 - $351,129	-351,129 Reduced 47.17%	393,248 $306,000
Q1 2022 May 16, 2022	BUY	$0.9 - $8.39 $669,939 - $6.25 Million	744,377 New	744,377 $674,000
Q4 2021 Feb 14, 2022	SELL	$6.58 - $8.44 $881,331 - $1.13 Million	-133,941 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.16 - $8.47 $231,843 - $380,565	-44,931 Reduced 25.12%	133,941 $1.12 Million
Q2 2021 Aug 16, 2021	BUY	$5.75 - $7.59 $350,249 - $462,329	60,913 Added 51.64%	178,872 $1.21 Million
Q1 2021 May 17, 2021	BUY	$4.14 - $9.22 $324,923 - $723,622	78,484 Added 198.82%	117,959 $780,000
Q4 2020 Feb 16, 2021	BUY	$3.58 - $4.85 $141,320 - $191,453	39,475 New	39,475 $166,000
Q3 2020 Nov 16, 2020	SELL	$4.79 - $6.3 $134,771 - $177,256	-28,136 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.5 - $6.53 $13,801 - $20,027	-3,067 Reduced 9.83%	28,136 $171,000
Q1 2020 May 15, 2020	BUY	$5.25 - $9.9 $67,137 - $126,601	12,788 Added 69.44%	31,203 $171,000
Q4 2019 Feb 14, 2020	SELL	$5.84 - $10.51 $14,559 - $26,201	-2,493 Reduced 11.92%	18,415 $182,000
Q3 2019 Nov 14, 2019	BUY	$5.76 - $9.44 $50,728 - $83,138	8,807 Added 72.78%	20,908 $120,000
Q2 2019 Aug 14, 2019	SELL	$9.1 - $15.55 $420,511 - $718,565	-46,210 Reduced 79.25%	12,101 $110,000
Q1 2019 May 15, 2019	SELL	$12.5 - $18.48 $368,625 - $544,975	-29,490 Reduced 33.59%	58,311 $809,000
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $1.01 Million - $1.48 Million	66,113 Added 304.84%	87,801 $1.39 Million
Q3 2018 Nov 14, 2018	BUY	$6.45 - $21.6 $139,887 - $468,460	21,688 New	21,688 $420,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.2M

Call Options Held

26.2K

Put Options Held

8.6K

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $131M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Pro Qr Therapeutics N.V. Transaction History